Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study

por Patricia Bogas, Chamaida Plasencia-Rodriguez, Victoria Navarro-Compán, Carolina Tornero, Marta Novella-Navarro, Laura Nuño, Ana Martínez-Feito, Borja Hernández-Breijo, Alejandro Balsa
Publicado 2021

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

por Cristina Regueiro, Laura Nuño, Ana M. Ortiz, Diana Peiteado, Alejandro Villalba, Dora Pascual-Salcedo, Ana Martínez-Feito, Isidoro González-Alvaro, Alejandro Balsa, Antonio González
Publicado 2017

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies

por Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, Ana M. Ortiz, Alejandro Villalba, María Dolores Bóveda, Ana Martínez-Feito, Carmen Conde, Alejandro Balsa, Isidoro González-Alvaro, Antonio Gonzalez
Publicado 2021

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

por Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E. Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J. Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
Publicado 2021